Quince Therapeutics, Inc. (IRLA): SCHEDULE 13G filed Oct 14, 2026

Form type

SCHEDULE 13G

Filing date

Oct 14, 2026

Accession number

0001193125-26-421651

Filer

Quince Therapeutics, Inc. (CIK 1662774)